Guidelines on the management of drug-induced immune and secondary autoimmune, haemolytic anaemia.
Hill QA, Stamps R, Massey E, Grainger JD, Provan D, Hill A; British Society for Haematology Guidelines.
Br J Haematol. 2017 Apr;177(2):208-220. doi: 10.1111/bjh.14654. Epub 2017 Apr 3.
Autoimmune haemolytic anaemia.
Argüello Marina M, López Rubio M, Castilla García L.
Med Clin (Barc). 2023 Jan 5;160(1):30-38. doi: 10.1016/j.medcli.2022.07.021. Epub 2022 Nov 2.
Autoimmune Hemolytic Anemias: Classifications, Pathophysiology, Diagnoses and Management.
Loriamini M, Cserti-Gazdewich C, Branch DR.
Int J Mol Sci. 2024 Apr 12;25(8):4296. doi: 10.3390/ijms25084296.
Haemolytic uraemic syndrome.
Fakhouri F, Zuber J, Frémeaux-Bacchi V, Loirat C.
Lancet. 2017 Aug 12;390(10095):681-696. doi: 10.1016/S0140-6736(17)30062-4. Epub 2017 Feb 25.
Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting.
Jäger U, Barcellini W, Broome CM, Gertz MA, Hill A, Hill QA, Jilma B, Kuter DJ, Michel M, Montillo M, Röth A, Zeerleder SS, Berentsen S.
Blood Rev. 2020 May;41:100648. doi: 10.1016/j.blre.2019.100648. Epub 2019 Dec 5.
Hemolytic anemia.
Dhaliwal G, Cornett PA, Tierney LM Jr.
Am Fam Physician. 2004 Jun 1;69(11):2599-606.
Autoimmune haemolytic anaemia secondary to babesiosis: A review of reported cases and description of a novel association with cold antibody-mediated haemolytic anaemia.
Jacobs JW, Binns TC, Abels E, Tormey CA.
Br J Haematol. 2023 Apr;201(2):364-369. doi: 10.1111/bjh.18710. Epub 2023 Feb 20.
Diagnosis and management of Evans syndrome in adults: first consensus recommendations.
Fattizzo B, Marchetti M, Michel M, Cantoni S, Frederiksen H, Giordano G, Glenthøj A, González-López TJ, Murakhovskaya I, Napolitano M, Mingot ME, Arguello M, Patriarca A, Raso S, Vianelli N, Barcellini W.
Lancet Haematol. 2024 Aug;11(8):e617-e628. doi: 10.1016/S2352-3026(24)00144-3. Epub 2024 Jul 2.
Sovleplenib in patients with primary or secondary warm autoimmune haemolytic anaemia: results from phase 2 of a randomised, double-blind, placebo-controlled, phase 2/3 study.
Zhao X, Sun J, Zhang Z, Chen M, Gong T, He G, Li Y, Liu H, Li F, Li X, Zhou H, Wang X, Hong M, Lei L, Yin H, Luo X, Li Y, Fan S, Guo X, Shi MM, Su W, Zhang L, Han B, Zhang F.
Lancet Haematol. 2025 Feb;12(2):e97-e108. doi: 10.1016/S2352-3026(24)00344-2. Epub 2025 Jan 9.
Case of autoimmune haemolytic anaemia, possibly secondary to vedolizumab in ulcerative colitis, successfully treated with rituximab.
Temido MJ, Lopes S, Figueiredo P, Portela F.
BMJ Case Rep. 2024 Jun 26;17(6):e260586. doi: 10.1136/bcr-2024-260586.
